Fingolimod for Type 2 Diabetes Mellitus

Clinical trial NCT05307731 · RECRUITING

Trial details

NCT number: NCT05307731
Sponsor: General Hospital of Shenyang Military Region
Status: RECRUITING
Phase: Phase 4
Study type: INTERVENTIONAL

Diabetes Mellitus, Type 2

Start date: 2022-03-15
Primary completion: 2026-03-15
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.